Rad AI Secures $68 Mn to Advance Gen AI in Healthcare

This announcement builds on the momentum of Rad AI’s $60 million Series C round, marking a significant step in deploying AI more deeply into healthcare operations.

The US-based Rad AI has announced a strategic $8 million investment to expand its latest funding round, backed by four major US health systems: Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System.

This brings the total raised in Rad AI’s Series C round to $68 million. The investment seeks to revolutionize patient care at scale and expand the use of generative AI within hospitals and health networks nationwide.

This announcement builds on the momentum of Rad AI’s $60 million Series C round, marking a significant step in deploying AI more deeply into healthcare operations.

“It’s an honor to collaborate with these leading health systems to expand that impact even further, building solutions that improve care for millions of patients,” said Doktor Gurson, co-founder and CEO of Rad AI.

The investing health systems operate over 100 hospitals and care for millions of patients annually. Their support enables broad adoption of Rad AI’s radiology reporting and follow-up tools, especially in high-pressure care delivery settings.

“By integrating AI solutions directly into our radiologists’ workflows across our enterprise, while maintaining radiologist oversight, we expect to realize improved reporting efficiency, accuracy, and quality, all while reducing burnout for our radiologists,” said Andy Crowder, Chief Digital and AI Officer at Advocate Health.

Rad AI Impressions, the first generative AI tool to achieve broad adoption in radiology, automates the impression section of reports, saving radiologists over an hour per shift and allowing them to concentrate on more complex diagnostic tasks.

Rad AI Reporting enhances productivity with features like Omni Unchanged, which retrieves prior stable findings with a single phrase, reducing follow-up dictation time by 50% and spoken word count by 90%.

Its Omni Report functionality enables natural dictation while automatically populating structured templates, significantly lowering cognitive load and doubling reporting speed.

“Memorial Hermann invests in AI not just to adapt to technology, but to transform patient care and improve workflows,” said Feby Abraham, PhD, executive vice president and chief strategy officer for Memorial Hermann.

“We are always seeking partners who can deliver measurable impact on outcomes, efficiency, and improving the patient experience, and Rad AI checks all those boxes,” he added.

Rad AI Continuity addresses the critical challenge of follow-up care by automatically tracking and coordinating action on incidental findings. Early adopters improved follow-up exam completion rates from roughly 30% to 75%.

“We are pleased to invest in a company that is at the forefront of developing technology to make the jobs of physicians more convenient and efficient,” said Christian Rische, vice president and managing director, Corewell Health Ventures.

The investment cements Rad AI’s leadership in generative AI for healthcare.

Stay tuned for more such updates on Digital Health News.

Stay tuned for more such updates on Digital Health News